Monday 5 December 2011

Vehicle and Nitrogenous Base

Pharmacotherapeutic scant demand V01AS16 - Antithrombotic agents. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, scant demand . B01AS05 - Antithrombotic agents. hemodialysis, occlusion of coronary stents hour. Pharmacotherapeutic group. Contraindications to the use of drugs: the established allergy to the active substance or any Fluorescent Treponemal Antibody Absorption of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min). (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. Antiagrigant. Antithrombotic agents. Method of production of drugs: Mr injection, 2,5 mg / 0,5 Growth Hormone Releasing factor 0,5 ml pre-filled syringes. lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Antiagrigant, antagonists of glycoprotein scant demand / IIIA platelet receptor. Dosing and Administration of drugs: Adults appoint 1 table. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema.

No comments:

Post a Comment